A Trial to Evaluate Efficacy of Heart-protecting Musk Pill

Exclusion Criteria

• •1. History of acute myocardial infarction, vascular reconstruction, CABG or PCI within half of a year.
• •2. Prepared to undertake CABG or PCI during this study.
• •3. Serious cardiovascular diseases: sustained severe angina (CCS Ⅳ), refractory heart failure, cardiogenic shock, severe aortic stenosis or aortic insufficiency.
• •4. Severe respiratory diseases;
• •5. Diabetic patients with poor glycemic control (fasting blood glucose \> 200 mg/dl or 11.1mmol/L for more than twice within one month before the study entry).
• •6. Hypertensive patients with poor control of blood pressure, systolic pressure≥180mmHg or diastolic pressure≥110mmHg before entry.
• •7. Severe liver and kidney diseases,such as active liver disease, cirrhosis and uremia.
• •8. Any other severe diseases, such as malignant tumor, severe anemia and severe renal artery stenosis.
• •9. Unable or unwilling to sign informed consent form.
• •10. Join another trial or has received random allocation of this study within one month before entry.
• •11. Pregnant or who were attempting to become pregnant.
• •12. Patients who are regarded as not being suitable participants by the study investigators.